Here’s whether LifeStance Health Group, Inc. Common Stock (LFST) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.29% over 10 days); RSI 51 — healthy momentum range; strong 1-year return of +31.3%. Currently 16.9% off its 52-week high. Score: +6/7.
LFST is in a confirmed uptrend, trading above both its 50-day ($7.00) and 200-day ($6.39) moving averages. An RSI of 51.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +31.3% compares to +27.9% for SPY (beat the market by 3.4%).
$10,000 invested 1 year ago→ $13,126 today
vs. S&P 500 (SPY) — same period beat market by 3.4%